Inspire Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.88M Hold
130,000
1.22% 20
2025
Q4
$7.01M Buy
130,000
+13,000
+11% +$625K 1.15% 22
2025
Q3
$5.28M Buy
117,000
+10,000
+9% +$467K 0.96% 39
2025
Q2
$4.95M Buy
107,000
+35,000
+49% +$1.72M 1.02% 33
2025
Q1
$4.39M Buy
72,000
+14,000
+24% +$816K 1.04% 30
2024
Q4
$3.28M Sell
58,000
-45,500
-44% -$2.54M 0.84% 48
2024
Q3
$5.36M Buy
103,500
+29,044
+39% +$1.36M 1.48% 15
2024
Q2
$3.09M Buy
74,456
+20,315
+38% +$909K 1.02% 29
2024
Q1
$2.94M Buy
54,141
+24,805
+85% +$1.26M 1.64% 14
2023
Q4
$1.51M Buy
+29,336
New +$1.54M 1.55% 13

Other funds holding BMY

Inspire Trust Company's BMY Position: Q1 2026 in Review

Inspire Trust Company held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 130,000 shares worth $7.88M. The position accounts for 1.22% of the portfolio, ranked #20.

Inspire Trust Company first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Inspire Trust Company held 130,000 shares of Bristol-Myers Squibb worth $7.88M as of Q1 2026.
  • Inspire Trust Company left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 1.22% of Inspire Trust Company's portfolio in Q1 2026, its #20 holding.
  • Inspire Trust Company first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Inspire Trust Company's 13F filing for Q1 2026, filed 12 May 2026.